Clinical Trials in Baltimore

Showing 4561-4580 of 22,332 trials

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

NCT03914794

This phase II trial studies how well Pemigatinib (an orally administered inhibitor of fibroblast growth factor receptors 1, 2, and 3) works in non-muscle invasive bladder cancer (NMIBC) patients with recurrent tumors and a prior history of low- or intermediate-risk NMIBC tumors. Participants will receive pemigatinib for 4-6 weeks prior to standard of care transurethral resection of bladder tumor (TURBT).

Bladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins30 participantsStarted Oct 2020

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States • Syracuse, New York, United States +3 more locations

Active Not Recruiting< 1 mile

Biobank For MS And Other Demyelinating Diseases

NCT00445367

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Multiple SclerosisTransverse MyelitisNeuromyelitis Optica+2 more

Accelerated Cure Project for Multiple Sclerosis3,226 participantsStarted May 2006

Phoenix, Arizona, United States • Stanford, California, United States • Aurora, Colorado, United States +7 more locations

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Biobank For MS And Other Demyelinating Diseases

Find Trials by Condition in Baltimore

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

Combined Cryotherapy With Compression Versus Cryotherapy Alone After Orthopaedic Surgery

Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study

Main Study: Influence on Plasticity of Brain Temperature Sub-Study: Phase Triggered Paired Associative Stimulation (PAS)

A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Collection of Tissue Specimens for Analysis and Establishment of Cell Cultures

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery